KNSTRN, a Poor Prognostic Biomarker, Affects the Tumor Immune Microenvironment and Immunotherapy Outcomes in Pan-Cancer
Disease Markers · 2023
DOI: 10.1155/2023/6729717 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Markers, 2023. Verfasst von Wanli Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Provincial Pearl River Talents Program, Guangzhou Technology Project.
Abstract (Originalsprache)
Kinetochore-localized astrin- (SPAG5-) binding protein (KNSTRN) is mainly involved in mitosis. Somatic mutations in KNSTRN are known to lead to the occurrence and development of certain tumors. However, the role of KNSTRN in the tumor immune microenvironment (TIME) as a tumor prognostic biomarker and potential therapeutic target has not been clarified. Accordingly, in this study, we aimed to investigate the role of KNSTRN in the TIME. mRNA expression, cancer patient prognosis, and correlations between KNSTRN expression and immune component infiltration were analyzed using Genotype-Tissue Expression, The Cancer Genome Atlas, Cancer Cell Line Encyclopedia, Human Protein Atlas, ImmuCellAI, TIMER2.0, and KM-Plotter. The Genomics of Drug Sensitivity in Cancer database was used to evaluate the relationship between KNSTRN expression and the half maximal inhibitory concentration (IC50) of several anticancer drugs, and gene set variation analysis was performed. Data were visualized using R version 4.1.1. KNSTRN expression was upregulated in the majority of cancers and was associated with a worse prognosis. Additionally, KNSTRN expression was highly correlated with the infiltration of multiple immune components in the TIME and was related to a poor prognosis in tumor patients receiving immunotherapy. KNSTRN expression was also positively correlated with the IC50 of various anticancer drugs. In conclusion, KNSTRN may be a significant prognostic biomarker and promising target for oncotherapy in numerous cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
- Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
ORCID-Profile: Yanxia Liao, Chengdong Liu, Li Liu, Xiaohan Zhou
Förderung
- National Natural Science Foundation of China
- Guangdong Provincial Pearl River Talents Program
- Guangzhou Technology Project
- Nanfang Hospital
- Southern Medical University
- China Postdoctoral Science Foundation
- Natural Science Foundation of Guangdong Province
- Natural Science Foundation of Shenzhen City
Zitieren
APA
Zhang, W., Liao, Y., Liu, C., Liu, L., & Zhou, X. (2023). KNSTRN, a Poor Prognostic Biomarker, Affects the Tumor Immune Microenvironment and Immunotherapy Outcomes in Pan-Cancer. Disease Markers. https://doi.org/10.1155/2023/6729717
Vancouver
Zhang W, Liao Y, Liu C, Liu L, Zhou X. KNSTRN, a Poor Prognostic Biomarker, Affects the Tumor Immune Microenvironment and Immunotherapy Outcomes in Pan-Cancer. Disease Markers. 2023. doi:10.1155/2023/6729717
BibTeX
@article{Zhang2023,
author = {Zhang, Wanli and Liao, Yanxia and Liu, Chengdong and Liu, Li and Zhou, Xiaohan},
title = {KNSTRN, a Poor Prognostic Biomarker, Affects the Tumor Immune Microenvironment and Immunotherapy Outcomes in Pan-Cancer},
journal = {Disease Markers},
year = {2023},
doi = {10.1155/2023/6729717}
}
EUVIMED